Clinical and transesophageal echocardiographic variables for prediction of thromboembolic events in patients with nonvalvular atrial fibrillation at low-intermediate risk

Journal of Cardiology

Volumn 60, Issue 6, 2012, Pages 484-488

  Sasahara, Etsuko ^a   Nakagawa, Keiko ^a   Hirai, Tadakazu ^a   Takashima, Shutaro ^a   Ohara, Kazumasa ^a   Fukuda, Nobuyuki ^a   Nozawa, Takashi ^a   Tanaka, Kortaro ^a   Inoue, Hiroshi ^a  

^a TOYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Nonvalvular atrial fibrillation; Prognosis; Transesophageal echocardiography

Indexed keywords

ADULT; AORTA ATHEROSCLEROSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; RISK ASSESSMENT; SCORING SYSTEM; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FORECASTING; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; STROKE; THROMBOEMBOLISM;

EID: 84869083342     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.09.001     Document Type: Article

References (30)

1. Fang M.C., Go A.S., Chang Y., Borowsky L., Pomernacki N.K., Singer D.E., for the ATRIA Study Group Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol 2008, 51:810-815.
2. Stroke Risk in Atrial Fibrillation Working Group Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 2008, 39:1901-1910.
3. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001, 285:2864-2870.
4. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998, 128:639-647.
5. Iwama M., Kawasaki M., Tanaka R., Ono K., Watanabe T., Hirose T., Nagaya M., Noda T., Watanabe S., Minatoguchi S. Left atrial appendage emptying fraction assessed by a feature-tracking echocardiographic method is a determinant of thrombus in patients with nonvalvular atrial fibrillation. J Cardiol 2012, 59:329-336.
6. Nakagawa K., Hirai T., Shinokawa N., Takashima S., Nozawa T., Asanoi H., Inoue H. Aortic spontaneous echocardiographic contrast and hemostatic markers in patients with nonrheumatic atrial fibrillation. Chest 2002, 121:500-505.
7. The French Study of Aortic Plaques in Stroke Group Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996, 334:1216-1221.
8. Wysokinski W.E., Ammash N., Sobande F., Kalsi H., Hodge D., McBane R.D. Predicting left atrial thrombi in atrial fibrillation. Am Heart J 2010, 159:665-671.
9. Fatkin D., Kelly R.P., Feneley M.P. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994, 23:961-969.
10. Mügge A., Kühn H., Nikutta P., Grote J., Lopez A.G., Daniel W.G. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol 1994, 23:599-607.
11. Bernhardt P., Schmidt H., Hammerstingl C., Lüderitz B., Omran H. Patients with atrial fibrillation and dense spontaneous echo contrast at high risk: a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol 2005, 45:1807-1812.
12. Leung D.Y.C., Black I.W., Cranney G.B., Hopkins A.P., Walsh W.F. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 1994, 24:755-762.
13. Di Tullio M.R., Homma S., Jin Z., Sacco R.L. Aortic atherosclerosis, hypercoagulability, and stroke: the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study. J Am Coll Cardiol 2008, 52:855-861.
14. Ward R.P., Don C.W., Furlong K.T., Lang R.M. Predictors of long-term mortality in patients with ischemic stroke referred for transesophageal echocardiography. Stroke 2006, 37:204-208.
15. Khumri T.M., Idupulapati M., Rader V., Nayyar S., Stoner C.N., Main M.L. Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation. Am J Cardiol 2007, 99:1733-1736.
16. 2 risk factors. PACE 2009, 32:981-986.
17. Ohara K., Hirai T., Fukuda N., Sakurai K., Nakagawa K., Nozawa T., Inoue H. Relation of left atrial blood stasis to clinical risk factors in atrial fibrillation. Int J Cardiol 2009, 132:210-215.
18. Rader V.J., Khumri T.M., Idupulapati M., Stoner C.N., Magalski A., Main M.L. Clinical predictors of left atrial thrombus and spontaneous echocardiographic contrast in patients with atrial fibrillation. J Am Soc Echocardiogr 2007, 20:1181-1185.
19. 2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol 2009, 54:2032-2039.
20. Lip G.Y.H., Nieuwlaat R., Pisters R., Lane D.A., Crijins H.J.G.M. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest 2010, 137:263-272.
21. 2-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol 2011, 58:2380-2385.
22. Heppell R.M., Berkin K.E., McLenachan J.M., Davies J.A. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 1997, 77:407-411.
23. Shinohara H., Fukuda N., Soeki T., Takeichi N., Tui Y., Tamura Y., Oki T. Relationship between flow dynamics in the left atrium and hemostatic abnormalities in patients with nonvalvular atrial fibrillation. Jpn Heart J 1998, 39:721-730.
24. Ohara K., Inoue H., Nozawa T., Hirai T., Iwasa A., Okumura K., Lee J.D., Shimizu A., Hayano M., Yano K. Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation. Int J Cardiol 2007, 126:316-321.
25. Inoue H., Nozawa T., Okumura K., Lee J.D., Shimizu A., Yano K. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism. Chest 2004, 126:687-692.
26. Nakagawa K., Hirai T., Sakurai K., Ohara K., Nozawa T., Inoue H. Thoracic aortic plaque enhances hypercoagulability in patients with nonvalvular atrial fibrillation. Circ J 2007, 71:52-56.
27. Inoue H., Nozawa T., Hirai T., Goto S., Origasa H., Shimada K., Uchiyama S., Hirabayashi T., Koretsune Y., Ono S., Hasegawa T., Sasagawa Y., Kaneko Y., Ikeda Y., J-TRACE Investigators Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE. Circ J 2010, 74:650-654.
28. Atarashi H., Inoue H., Okumura K., Yamashita T., Kumagai N., Origasa H., for the J-RHYTHM Registry Investigators Present status of anticoagulation treatment in Japanese patients with atrial fibrillation. Circ J 2011, 75:1328-1333.
29. Yamashita T. Frontiers of anticoagulation therapy for atrial fibrillation. J Cardiol 2011, 58:1-5.
30. Atarashi H., Inoue H., Okumura K., Yamashita T., Origasa H. Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation-the J-RHYTHM Registry study design. J Cardiol 2011, 57:95-99.